Pilot Study on Concurrent Cisplatin-based Chemotherapy Combined With Vaccination Therapy With the P16_37-63 Peptide in Patients With HPV- and p16INK4a-positive Cancer
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Human papillomavirus vaccine (Primary)
- Indications Human papillomavirus infections
- Focus Pharmacodynamics
- Acronyms VICORYX-2
- Sponsors Oryx GmbH & Co
- 30 Jun 2017 Status changed from active, no longer recruiting to completed.
- 28 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 31 Mar 2016 Planned End Date changed from 1 Mar 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov record.